IGFBP6 and prostate carcinoma: IGFBP6 inhibits growth in a number of IGF-II-dependent cancers, including rhabdomyosarcoma [13], neuroblastoma [14], colon cancer [15, 16], lung cancer [17], prostate cancer [18], breast cancer [19, 20] and ovarian cancer [21].